#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type II Non-Hodgkin's lymphoma refractory Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Polymyositis Metachromatic leukodystrophy Mantle cell lymphoma recurrent Retinopathy of prematurity Follicular lymphoma stage I Myotonic dystrophy Cholangiosarcoma Hairy cell leukaemia Chondrosarcoma metastatic Squamous cell carcinoma of the hypopharynx Cutaneous T-cell lymphoma refractory Haemophilia B without inhibitors More trials…

    Learn about Rare Diseases

    Optic glioma – Basic Information Choroid melanoma – Trials in Disease Congenital nephrogenic diabetes insipidus Retinoblastoma – Basic Information Leiomyosarcoma metastatic – Treatment Rett syndrome Mantle cell lymphoma refractory Angiosarcoma metastatic – Life with Disease Encephalitis autoimmune – Basic Information Niemann-Pick disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludeoxyglucose (18F) Omp64 Fludarabine Fosaprepitant Ecoo18A Levamlodipine Succinate Ecopipam Hydrochloride Emapalumab Pabinafusp Alfa SOFTISAN 378 Bempedoic Acid Human Normal Immunoglobulin Prs-344 Io103 Acetate Fremanezumab Doxribtimine Msv/As Gindameran Sorafenib Anselamimab More therapies…

    Learn about Your Condition

    Corneal graft rejection Renal disorder Pleomorphic leiomyosarcoma Bile duct cancer Vulval cancer recurrent Von Willebrand's disease Thalassaemia beta Hereditary optic atrophy HER2 protein overexpression Pneumonia bacterial Ovarian cancer recurrent Pain Cortisol abnormal Noninfective chorioretinitis Anal incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Ebastine and Mebeverine for Treating Irritable Bowel Syndrome in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • Ebastine
    • Mebeverine Hydrochloride
    Belgium

  • Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Anhydrous Ropivacaine Hydrochloride
    • Mepivacaine Hydrochloride
    Sweden

  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Acalabrutinib
    • Cyclophosphamide
    Germany Greece

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Etoposide
    Belgium France

  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • B-cell lymphoma
    Investigated Drugs:
    • Pembrolizumab
    France Germany Italy The Netherlands Portugal Sweden

  • Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Mesna
    • Filgrastim
    • Ifosfamide
    Austria Belgium Finland Germany Greece Hungary +2
Previous Page
1 … 580 581 582 583 584 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!